Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Rockx

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Science (New York, N.Y.)|April 19, 2020
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate modelBarry Rockx, Thijs Kuiken, Sander Herfst, et al.
Science Immunology|June 23, 2022
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinctAnna Z Mykytyn, Melanie Rissmann, Adinda Kok, et al.
The Lancet. Infectious Diseases|July 28, 2024
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trialIsabel Leroux-Roels, Chittappen Kandiyil Prajeeth, Amare Aregay, et al.
Journal of Virology|November 19, 2010
Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaquesDavid Safronetz, Barry Rockx, Friederike Feldmann, et al.
Nature Communications|July 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
Nature Communications|July 27, 2022
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
EMBO Molecular Medicine|October 21, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibodyTingting Li, Hongmin Cai, Yapei Zhao, et al.
BMC Infectious Diseases|December 28, 2019
Study protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: the ZIKAlliance consortiumVivian I Avelino-Silva, Philippe Mayaud, Adriana Tami, et al.
Nature Communications|May 28, 2021
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infectionArvind Gharbharan, Carlijn C E Jordans, Corine GeurtsvanKessel, et al.
BMJ Open|December 16, 2020
Zika virus infection in pregnancy: a protocol for the joint analysis of the prospective cohort studies of the ZIKAlliance, ZikaPLAN and ZIKAction consortiaA E Ades, Elizabeth B Brickley, Neal Alexander, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Science (New York, N.Y.)|April 19, 2020
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate modelBarry Rockx, Thijs Kuiken, Sander Herfst, et al.
Science Immunology|June 23, 2022
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinctAnna Z Mykytyn, Melanie Rissmann, Adinda Kok, et al.
The Lancet. Infectious Diseases|July 28, 2024
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trialIsabel Leroux-Roels, Chittappen Kandiyil Prajeeth, Amare Aregay, et al.
Journal of Virology|November 19, 2010
Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaquesDavid Safronetz, Barry Rockx, Friederike Feldmann, et al.
Nature Communications|July 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
Nature Communications|July 27, 2022
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
EMBO Molecular Medicine|October 21, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibodyTingting Li, Hongmin Cai, Yapei Zhao, et al.
BMC Infectious Diseases|December 28, 2019
Study protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: the ZIKAlliance consortiumVivian I Avelino-Silva, Philippe Mayaud, Adriana Tami, et al.
Nature Communications|May 28, 2021
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infectionArvind Gharbharan, Carlijn C E Jordans, Corine GeurtsvanKessel, et al.
BMJ Open|December 16, 2020
Zika virus infection in pregnancy: a protocol for the joint analysis of the prospective cohort studies of the ZIKAlliance, ZikaPLAN and ZIKAction consortiaA E Ades, Elizabeth B Brickley, Neal Alexander, et al.
Pageof 12